高级搜索

沉默BRG1基因对人胶质瘤细胞增殖的影响及其机制

时梅林, 梅鹏金, 范月超, 李中林, 白 津, 徐 凯, 郑骏年

时梅林, 梅鹏金, 范月超, 李中林, 白 津, 徐 凯, 郑骏年. 沉默BRG1基因对人胶质瘤细胞增殖的影响及其机制[J]. 肿瘤防治研究, 2013, 40(12): 1134-1137. DOI: 10.3971/j.issn.1000-8578.2013.12.006
引用本文: 时梅林, 梅鹏金, 范月超, 李中林, 白 津, 徐 凯, 郑骏年. 沉默BRG1基因对人胶质瘤细胞增殖的影响及其机制[J]. 肿瘤防治研究, 2013, 40(12): 1134-1137. DOI: 10.3971/j.issn.1000-8578.2013.12.006
SHI Meilin, MEI Pengjin, FAN Yuechao, LI Zhonglin, BAI Jin, XU Kai, ZHENG Junnian. Silence of BRG1 Gene Regulates Proliferation of Human Glioma Cell[J]. Cancer Research on Prevention and Treatment, 2013, 40(12): 1134-1137. DOI: 10.3971/j.issn.1000-8578.2013.12.006
Citation: SHI Meilin, MEI Pengjin, FAN Yuechao, LI Zhonglin, BAI Jin, XU Kai, ZHENG Junnian. Silence of BRG1 Gene Regulates Proliferation of Human Glioma Cell[J]. Cancer Research on Prevention and Treatment, 2013, 40(12): 1134-1137. DOI: 10.3971/j.issn.1000-8578.2013.12.006

沉默BRG1基因对人胶质瘤细胞增殖的影响及其机制

详细信息
    作者简介:

    时梅林(1982- ),女,硕士在读,讲师,主要从事肿瘤基因治疗分子生物学研究

    通讯作者:

    郑骏年,E-mail: jnzheng@xzmc.edu.cn

  • 中图分类号: R739.41

Silence of BRG1 Gene Regulates Proliferation of Human Glioma Cell

  • 摘要: 目的 探讨小干扰RNA(siRNA)沉默胶质瘤细胞BRG1基因表达对其增殖的影响及其机制。方法 化学合成BRG1 siRNA,脂质体介导转染胶质瘤U251和U87细胞。CCK-8细胞增殖实验检测细胞增殖,流式细胞仪分析细胞周期变化,Western blot检测BRG1、cyclin家族、CDK抑制剂蛋白表达水平。结果 转染BRG1 siRNA可以有效减少胶质瘤U251和U87细胞BRG1表达,细胞增殖下降,G1期细胞增加。BRG1沉默后cyclin D1和cyclin B1表达降低,CDK抑制剂p21和p27没有明显变化。结论 沉默胶质瘤细胞BRG1表达影响细胞周期蛋白使细胞停滞在G1期,最终抑制胶质瘤细胞增殖。

     

    Abstract: Objective To investigate the effect of siRNA silencing BRG1 gene on glioma cell proliferation and its molecular mechanism. Methods Chemically synthesized small interfering RNA targeting BRG1 was transfected into human glioma cell lines U251 and U87 by siLentFect Lipid Reagent. The proliferation of both glioma cells after BRG1 interference was measured by CCK-8 assay. The cell cycles of glioma cells were detected by flow cytometry.The expression levels of BRG1, cyclin family and CDK inhibitor proteins were detected by western blot. Results BRG1 interference could drastically decrease the ability of cell proliferation in both glioma cells. The G1 population in both glioma cells treated by BRG1 siRNA was increased signifi cantly than that in the cells treated by control siRNA. The Western blot results showed that BRG1 knock-down inhibited expression of both cyclin D1 and cyclin B1, but the expression of p21 and p27. Conclusion BRG1 siRNA could effectively decrease the expression of BRG1 in glioma cell and arrest cell cycle at G1 phase and signifi cantly inhibit the cell proliferation.

     

  • [1] Chen SR,Wang ZX,Chen YY. Progresses in relations between microRNA and invision of gliomas[J].Zhong Liu Fang Zhi Yan Jiu, 2011, 38 (1) : 106-8. [陈寿仁,王占祥,陈玉英. microRNA 与胶质瘤侵袭性关系的研究进展[J].肿瘤防治研究,2011, 38 (1) : 106-8.]
    [2] Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer[J]. Oncogene, 2009, 28(14):1653-68.
    [3] Wang W, Xue Y, Zhou S, et al. Diversity and specialization of mammalian SWI/SNF complexes[J]. Genes Dev, 1996, 10(17): 21 17-30.
    [4] Simone C. SWI/SNF: The crossroads where extracellular signaling pathways meet chromatin[J]. J Cell physiol, 2006, 207(2):309-14.
    [5] Chai B, Huang J, Cairns BR, et al. Distinct roles for the RSC and SWI/SNF ATP-dependent chromatin remodelers in DNA doublestrand break repair[J]. Genes Dev, 2005,19(14):1656-61.
    [6] Flowers S, Nagl NG Jr, Beck GR Jr, et al. Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation[J]. J Biol Chem, 2009, 284(15):10067-75.
    [7] Glaros S, Cirrincione GM, Muchardt C, et al. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy[J]. Oncogene, 2007, 26(49): 7058-66.
    [8] Becker TM, Haferkamp S, Dijkstra MK, et al. The chromatin remodellling factor BRG1 is novel binding partner of the tumor suppressor p16INK4a[J]. Mol Cancer, 2009, 8: 4.
    [9] Kang H, Cui K, Zhao K. BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI[J]. Mol Cell Biol, 2004, 24 (3):1188-99.
    [10] Wang X, Sansam CG, Thom CS, et al. Oncogenesis caused by loss of the SNF tumor suppressor is dependent on activity of BRG1, the ATPase of SWI/SNF chromatin remodeling complex[J]. Cancer Res,2009, 69(20):8094-101.
    [11] Naidu SR, Love IM, Imbalzano AN, et al. The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells[J]. Oncogene,2009, 28 (27): 2492-501.
    [12] Keenen B, Qi H, Saladi SV, et al. Heterogeneous SWI/SNF chromatin remodeling complexs promote expression of microphthalmia-associated transcription factor target genes in melanoma[J]. Oncogene, 2010, 29(1):81-92.
    [13] Lin H, Wong RP, Martinka M, et al. BRG1 expression is increased in human cutaneous melanoma[J]. Br J Dermatol,2010, 163 (3) :502-10.
    [14] Zhang B, Chambers KJ, Faller DV, et al. Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation[J]. Oncogene, 20 07, 26(50): 7153-7.
    [15] Bochar DA, Wang L, Beniya H, et al. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer[J]. Cell, 2000, 102(2): 257-65.
    [16] Marignani PA, Kanai F, Carpenter CL. LKB1 associates with Brg1 and necessary for Brg1-induced growth arrest[J]. J Biol Chem, 20 01, 276(35):32415-8.
    [17] Zhang B, Chambers KJ, Leprince D, et al. Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control[J]. Oncogene, 2009, 28(5): 651-61.
计量
  • 文章访问数:  1154
  • HTML全文浏览量:  19
  • PDF下载量:  439
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-10-14
  • 修回日期:  2012-11-27
  • 刊出日期:  2013-12-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭